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ABSTRACTSdeveloped a total of 9 pseudoaneurysms (6.3%:one bilateral), none of
which required secondary intervention. Median pseudoaneurysm diam-
eter was 8.4mm at diagnosis. Median follow up was 24 months. Three
pseudoaneurysms had resolved at one year and a fourth by 2 years. Four
patients died at a median of 15 months; none due to pseudoaneurysms.
Conclusion: There is a low rate of pseudoaneurysm formation after fascial
closure and no clinical impact in the mid-term. Fascial closure remains a
safe and minimally invasive option.
0963: OUTCOMES FOLLOWING ARTERIAL ANGIOPLASTY IN SYMPTOM-
ATIC INFRAPOPLITEAL DISEASE: A SYSTEMATIC REVIEW OF THE
LITERATURE
James Glasbey 2, David Bosanquet 1, Michael Lewis 1. 1Department of
Surgery, Royal Glamorgan Hospital, Llantrisant, South Wales, UK; 2Cardiff
University School of Medicine, Cardiff, UK.
Aim: Despite a wealth of research into percutaneous intervention for
arterial disease, the role of angioplasty in treating symptomatic infrapo-
pliteal disease remains undeﬁned. Whilst historically, surgical revascu-
larisation has been the cornerstone of its management, angioplasty is
recommended for limb salvage where open surgery is contra-indicated.
Should non-inferiority be demonstrated, increasing use of endovascular
techniques may reduce the morbidity associated with open surgery. This
study's aims are to summarise reported outcomes in endovascular crural
disease management.
Methods: A systematic review of the Cochrane Library, OVID/Medline and
Pubmedwas performed from 1990 to December 2012. Keywords included:
‘infrapopliteal', ‘angioplasty', ‘stenting', ‘outcomes'. Related article func-
tions were also searched. Clinical and technical success parameters were
recorded.
Results: No level I evidence exists as to the superiority of bypass over
percutaneous transluminal angioplasty (PTA). Two randomised controlled
trials (RCT) demonstrated non-superiority of bare-metal stenting over PTA,
whilst initial reports from three RCTs suggest a role for sirolimus/ever-
olimus/paclitaxel-eluting stents in improving clinical outcomes.
Conclusions: A level I, intention-to-treat study of angioplasty+/-stenting
vs. bypass will be required before the precise role of infrapopliteal an-
gioplasty can be deﬁned. Drug-eluting stents have shown early promise
and may thus facilitate further paradigm shift away from more morbid
surgical management techniques.
1009: ROLE OF ANGIOGRAPHIC RUN OFF SCORE AS A TOOL TO PREDICT
LONG TERM OUTCOME FOLLOWING LOWER LIMB BYPASS SURGERY
Manish George, Rosie Cadwallader, Jonathan Ghosh. Vascular Surgery
Department, University Hospital South Manchester, Manchester, UK.
Objectives: To evaluate the role of peripheral artery run-off scoring as
predicted by the SVS/ISCVS system in predicting the fate of infrainguinal
bypass grafts.
Methods: A retrospective cohort study of all patients enrolled in a Duplex-
based lower limb graft surveillance programme since January 2007 at a
tertiary vascular centre. Outﬂow vessels were graded according to the SVS/
ISCVS Ad Hoc scoring system based on preoperative magnetic resonance
angiography. All candidates were followed up for re-intervention or graft
occlusion until January 2012 or discharge from the surveillance
programme.
Results: 178 patients underwent follow up after infrainguinal bypass. The
primary indication for surgery was: critical limb ischaemia (60%); aneu-
rysm (28%); claudication (10%), and trauma (2%). The median follow up
timewas 28 months (range, 3-56 months). Primary patency rate was 79.2%
at the completion of follow up. Secondary patency rate was achieved in an
additional 14.1%. Twelve subjects had graft failure of whom 8 required
amputation. Mean run off score in the re-intervention group was 6.0, 6.5 in
those resulting in amputation compared to 5.5 in those with primary
patency. ANOVA p-value 0.218.
Conclusions: Preoperative run off score did not predict re-intervention or
mid term graft patency.
1032: ULTRASOUND GUIDED FOAM SCLEROTHERAPY (UGFS) FOR
ACTIVE VENOUS ULCERATION e A 5-YEAR COHORT
Andrei Tanase, Gagandeep Grover, Alan Elstone, Simon Ashley. Derriford
Hospital, Department of Vascular Surgery, Plymouth, UK.Aim: Ultrasound guided foam sclerotherapy (UGFS) for treatment of CVU
(chronic venous ulceration) has demonstrated favourable results in pre-
liminary studies. This study analyses healing and recurrence rates in
CEAP6 ulcers treated with UGFS.
Method: Between 2007 and 2012, 60 patients (63 legs) underwent UGFS
with sodium tetradecyl-sulphate(STS) for CEAP6 ulcers. All patients were
followed up at 2.5 months both clinically and venous duplex was per-
formed before and after treatment. We analysed a prospectively collected
database and calculated venous occlusion rates, 12 month healing and
recurrence rates.
Results: 63 legs, 43 primary; 20 recurrent. Median time ulcer active 15
months (IQR 9 - 24); range 5 months e 17 years. At a median follow-up 2.5
months 57(90.5%) achieved full occlusion; 3(4.8%) short segment occlu-
sion, 4(4.8%) failed to occlude. 13 required repeat treatment. 2 pts reported
thrombophlebitis. 10 patients excluded from outcome analysis. 37(70%)
healed at a median time of 4months; 13(24.5%) at 3months, 24(45.3%) at
6months, 30(56.6%) at 12months. 14(28.3%) signiﬁcantly reduced and
healing; 7 almost healed and discharged; 12 month recurrence rate
2(3.7%).
Conclusions: USFS is a feasible component of the leg ulcer service and a
safe and effective means of securing superﬁcial vein occlusion as an
alternative to surgery.
1049: GRAFT INFECTION FOLLOWING VASCULAR SURGERY: INCIDENCE,
MANAGEMENT APPROACH AND OUTCOMES
Pavlos Iosiﬁdis, Mohamed Barakat, Jessica Veitch, Anoushka Kansara,
Carys Bather, Sameh Dimitri, Maher Hammish. Countess of Chester
Hospital, Chester, UK.
Aim: The aim of this study is to determine the incidence of graft infection
in our vascular unit, our management approach and outcome.
Methods: A retrospective study from case notes and a prospective data-
base of 168 patients who underwent vascular surgery with graft insertion
from January 2008 to December 2011. Patient demographic, type and site
of surgery, CEPOD grade of surgery, antibiotic prophylaxis, onset of graft
infection and treatment options were included in the data.
Results: 168 patients were included in our study. Carotid endarterectomy
(CEA) was the most performed procedure (48.8%) followed by femoral
bypass/endarterectomy (32.8%) and aortic surgery (18.4%). The majority of
the operations were elective 78% and 22 % were emergency. Cefuroxime,
Teicoplanin and Gentamicin were prophylactic antibiotics of choice in our
unit. Only 4 (2.38%) cases of graft infection were identiﬁed (2 CEA, 1 Aorto
by-Femoral bypass, 1 Femoro- popliteal bypass). All these patients un-
derwent removal of the graft and reconstructive vascular surgery. One
patient had an amputation as consequence of graft infection despite
reconstructive surgery. There was no mortality.
Conclusion: Our graft infection rate is very low with triple prophylactic
antibiotics. Graft removal and reconstructive vascular surgery remain the
standard management approach.
1062: SYNCHRONOUS CAROTID ENDARTERECTOMY (CEA) AND CARDIAC
SURGERY (CS): A SINGLE CENTRE EXPERIENCE OVER THIRTEEN YEARS
Thomas Hubbard, Marc Bailey, Kathryn Grifﬁn, Julian Scott. Leeds Vascular
Institute, Leeds, UK.
Introduction: This study reports rationale for and outcome of synchro-
nous carotid endarterectomy (CEA) and cardiac surgery (CS) over thirteen
years in our institution.
Methods: Patients undergoing CEA and CS between 1998-2011 were
identiﬁed, casenotes retrieved and retrospectively reviewed. Patients were
divided into; previously neurologically symptomatic (CEAS) and asymp-
tomatic (CEAA) and followed up to present day.
Results: 20,320 patients underwent CS during the study period; 64 had
CEA. 14 were excluded due to casenote loss or destruction. Twenty seven
patients (54%) formed the CEAS group (12 completed strokes, 15 TIA)
with average EuroScore of 8.23; 23 formed the CEAA group with average
EuroScore of 8.33. The rationale for Carotid Doppler Ultrasound in CEAA
:carotid bruit in 10 (20%), routine work-up in 11 (22%), re-evaluation of
existing carotid lesion in 2 (4%). 80% of CEA were for high grade (70-99%)
stenosis, 10 patients (20%) had bilateral disease. Thirty day stroke/death
rate was 14% (12% CEAS vs. 16% CEAA, p¼0.3). The only predictor of 30
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ABSTRACTSday stroke/death on univariant analysis was preoperative stroke
(p¼0.02).
Conclusion: Rationale for CDUSS in asymptomatic patients pre CS is var-
iable and results in high numbers receiving CEA. National Guidelines for
CDUSS and CEA referral pre- CS are required.
1066: VASCULAR ALLOGRAFTS e THE UK PERSPECTIVE 2008-2012
Samuel Coulson, Fern Coxon, Dominic Dodd. Vascular Services, Shefﬁeld, UK.
Introduction: Cadaveric allografts provide one alternative for conduit
formation in peripheral vascular disease when autografts are unavailable
and prosthetic grafts pose too great a risk. We aimed to review the use of
vascular allografts in the UK to identify reasons for poor uptake.
Method: All incidences of vascular allografts in the UK were recorded.
Reporting forms at time of operation, then at regular intervals, were sent
to the operating surgeon. The forms recorded demographics, compre-
hensive management information, patient progress and professional
opinion.
Results: Allografts were used on eighteen occasions, including ﬁve
femoralepopliteal, three ilioefemoral and two aortoeiliac bypasses. Five
are currently in situ and ﬁve have been removed. Complications included
arterial infection, graft infection and severe limb ulceration. Users found
allografts easy to handle and many would utilise again.
Conclusion: Vascular allografts have not gained the widespread accep-
tance they have been afforded in Europe. The current dismal uptake will
delay the development of a solid evidence base and threaten the future of
the vascular allograft tissue bank. Users reported a good experience, with
the ultimate proof being repeated use by four surgeons. Will it take just
one exposure to highlight the practicalities of these grafts and encourage
further use?
1080: PERIOPERATIVE COMPLIANCE WITH VSGBI QUALITY IMPROVE-
MENT FRAMEWORK FOR MAJOR LIMB AMPUTATIONS IN A SINGLE
VASCULAR CENTRE
Matthew Kennedy, Nikhil Sharma, Sobath Premaratne, Anthony Jaipersad,
Arun Balakrishna, Catherine Merriman. Royal Shrewsbury and Telford
Hospitals NHS Trust, Shrewsbury, UK.
Aim: To determine whether our department complies with the quality
improvement framework for major amputations formulated by Vascular
Society of Great Britain and Ireland (VSGBI).
Methods: Retrospective audit of major limb amputations performed dur-
ing 12 month period until October 2012. Case notes, theatre records and
departmental vascular database were analysed and data collected using a
proforma formulated upon the VSBGI guideline.
Results: 41 patients had major amputations, 30 were male, average age
was 70.2 years (range 36-94). 22(54%) below-knee and 17(41.5%) above-
knee amputations were performed. All patients were assessed by a
vascular surgeon prior to surgery. 97%(39) procedures undertaken during
normal working hours. Following the decision to amputate, 73%(30) pa-
tients underwent the procedure within 48 hours. All operating surgeons
were either senior vascular registrars or performed under consultant su-
pervision. In 71%(29) anaesthesia was administered by a senior anaes-
thetist. Thromboprophylaxis administered for all patients and prophylactic
antibiotic therapy administered in 92%(38) of patients preoperatively.
Postoperatively all patients underwent physiotherapist led rehabilitation.
In-hospital mortality and 30-day mortality rates were 7.3%(3) and 9.7%(4)
respectively.
Conclusion: Perioperative management of lower limb amputations ac-
cording to the quality improvement framework published by VSGBI, can
be undertaken in a single vascular centre with acceptable outcome
results.
1149: CATHETER-DIRECTED THROMBOLYSIS IN ILIO-FEMORAL DEEP
VEIN THROMBOSIS
Hirah Rizki, Abhilash Paily, Gary Picken, Isam Osman, Abdusalam Abu-
Own. The Ipswich Hospital, Ipswich, UK.
Aim: The importance of thrombus removal through Catheter Directed
Thrombolysis (CDT) for acute ilio-femoral DVT is well recognized. The aim
of this study was to review outcomes following CDT in our hospital.
Methods: A retrospective review of case notes and imaging was under-
taken for all cases of CDT from January 2001 to December 2012. tPAwas used and administered through the popliteal vein. Patients were
thrombolysed for 24-72 hours. No patient had an IVC ﬁlter inserted prior
to CDT.
Results: 20 patients (mean age 36) underwent CDT for ilio-femoral DVTs.
Complete radiological clearance was achieved in 40% of patients. May-
Thurners Syndrome was identiﬁed as the leading cause in 30% of patients.
There was no in-hospital PE, cerebral bleeding or deaths. Minor bleeding,
from the catheter or cannula site, was noted in 64% of cases. One patient
developed recurrent DVT within 3month and three beyond 3months. One
patient developed a PE 7 months post CDT.
Conclusions: In our experience, CDT is a safe and successful treatment
option for ilio-femoral DVTs. Our local hospital guidelines for CDT have
facilitated the process of safe selection and delivery of this treatment. Our
results are in keeping with the ﬁndings of published data.
1167: THE POTENTIAL IMPACT ON CLINICAL OUTCOMES AND SERVICE
PROVISION OF VARIABILITY IN ULTRASOUND MEASUREMENT OF
PEAK SYSTOLIC VELOCITY IN A MULTI-CENTRE VASCULAR NETWORK
G. Martin, J.D. Hodgkinson, U. Jaffer, M. Aslam, N.J. Standﬁeld. Imperial
Vascular Unit, Imperial College Healthcare NHS Trust, St Mary’s Hospital
Campus, Paddington, London, UK.
Aims: Multi-centre snap shot assessment of peak systolic velocity (PSV)
measurement utilising a high ﬁdelity pulsatile ﬂow stimulator. Our aim is
to assess sources of variability in a multi-centre vascular network.
Methods: We assessed 12 operators, across 4 different sites, utilising a
reproducible waveform generated by a high ﬁdelity pulsatile ﬂow simu-
lator. Measurements of PSV with both pulsatile and continuous ﬂow
waveforms were assessed for potential sources of variability.
Results: Wide variability in measured PSV: Pulsatile waveform: mean
52.1cm/s (range 40.0 - 62.9cm/s) and continuous waveform: mean 51.2cm/
s (range 41.7 - 63.3cm/s). Cross-site variability was found to be greater than
intra-operator variability.
Conclusions: Sources of measurement variability include angle of inso-
nation, sample volume, internal spectral broadening, machine type and
calibration. Accurate and reproducible non-invasive grading of stenoses,
monitoring of their progression, and assessment of response to treatment
is crucial in managing peripheral vascular disease. The formation of
regional vascular networks following the VSGBI report, ‘Provision of Ser-
vices for Patients with Vascular Disease', means diagnostic duplex ultra-
sound maybe occurring on multiple sites by multiple operators.
Signiﬁcant variability in duplex ultrasound assessment across different
sites could lead to delayed, or mis-diagnosis of signiﬁcant lesions;
potentially leading to inappropriate invasive diagnostic procedures or
surgical interventions.
1169: ENDOVASCULAR ANEURYSM REPAIR IN NONAGENARIANS: A SYS-
TEMATIC REVIEW AND COMBINED ANALYSIS
James Wigley 1, Saran Shantikumar 2, Waseem Hameed 3, Ashok Handa 4.
1University Hospital Southampton, Southampton, UK; 2Bristol Heart Institute,
Bristol, UK; 3Kings College Hospital, London, UK; 4Nufﬁeld Department of
Surgery, Oxford, UK.
Aim: Endovascular aortic aneurysm repair (EVAR) promises a reduced
morbidity and mortality compared to open surgery, creating the oppor-
tunity for aneurysm repair in those previously considered unﬁt for inter-
vention. We determine the published incidence of complications and
survival after elective EVAR in nonagenarians.
Method: A systematic literature search was performed using the PubMed,
EMBASE and Cochrane databases up to December 2012. Two observers
independently screened search results and extracted data.
Results: Five retrospective reports were identiﬁed including 111 patients
(81% male) with a mean age of 91.6 years. The mean aneurysm size was
68.6mm. Comorbidities include hypertension (81%), ischaemic heart dis-
ease (50%), peripheral vascular disease (30%) and COPD (20%). There was
zero on-table mortality, 24 (22%) patients suffered perioperative medical
or surgical complications and 27 (24%) had endoleaks. Mean duration of
hospital stay was 4 days. Thirty-daymortality was 5%, and survival at 1-, 3-
and 5-years was 82%, 56% and 17% respectively.
Conclusions: The complication rates and longer-term survival after elec-
tive EVAR in carefully selected nonagenarians appears acceptable, but is
higher than reported in younger patients. The use of EVAR in this age
